Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and

Marjet J A M Braamskamp1, D Meeike Kusters, Hans J Avis

  • 1Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, j.a.braamskamp@amc.uva.nl.

Paediatric Drugs
|February 4, 2015
PubMed

Insights

Young adults with familial hypercholesterolemia (FH) showed good adherence and tolerability to statin therapy initiated in childhood. Most patients continued treatment for ten years with mild side effects, indicating long-term treatment success.

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) management aims to prevent premature atherosclerosis using statins.
  • While statins are effective and generally safe in adults, non-adherence is a significant challenge.

Purpose of the Study:

  • To assess the long-term tolerability and adherence to statin therapy in young adult patients with FH.
  • To evaluate outcomes 10 years after initiating statin treatment during childhood.

Main Methods:

  • A questionnaire was administered to 214 young adult FH patients who started statin therapy at least 10 years prior.
  • Adherence was defined as taking 80% or more of prescribed medication.
  • Tolerability was assessed by the percentage of patients discontinuing therapy due to side effects.

Main Results:

  • Follow-up was achieved in 205 patients (age 18-30 years).
  • 19.5% reported mild side effects (muscle/GI complaints); only 1.5% discontinued therapy.
  • 82.4% remained on statins, with 78.7% demonstrating good adherence; no serious adverse events occurred.

Conclusions:

  • Childhood-initiated statin therapy in FH patients is well-tolerated and demonstrates good long-term adherence.
  • Mild side effects were reported by a minority, with most patients continuing treatment successfully for a decade.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
98
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.8K